Cargando…
Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases
BACKGROUND: Concerns for recrudescence of Ehrlichia canis infection arise when immunosuppressive drugs are used to treat immune‐mediated diseases in dogs previously infected with E. canis. OBJECTIVES: Determine whether administration of prednisolone and cyclosporine would reactivate E. canis infecti...
Autores principales: | Sato, Masahiko, Veir, Julia K., Shropshire, Sarah B., Lappin, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255653/ https://www.ncbi.nlm.nih.gov/pubmed/32267035 http://dx.doi.org/10.1111/jvim.15750 |
Ejemplares similares
-
Characteristics of hemostasis during experimental Ehrlichia canis infection
por: Shropshire, Sarah, et al.
Publicado: (2018) -
Efficacy of Minocycline in Naturally Occurring Nonacute Ehrlichia canis Infection in Dogs
por: Jenkins, S., et al.
Publicado: (2017) -
A retrospective study of adverse effects of mycophenolate mofetil administration to dogs with immune‐mediated disease
por: Fukushima, Kenjiro, et al.
Publicado: (2021) -
A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs
por: Sato, M., et al.
Publicado: (2017) -
First Detection of Ehrlichia canis in Cerebrospinal Fluid From a Nonthrombocytopenic Dog with Meningoencephalitis By Broad‐Range PCR
por: Kaewmongkol, G., et al.
Publicado: (2016)